Results 61 to 70 of about 267,421 (217)

An electroencephalographic signature predicts antidepressant response in major depression

open access: yesNature Biotechnology, 2019
Antidepressants are widely prescribed, but their efficacy relative to placebo is modest, in part because the clinical diagnosis of major depression encompasses biologically heterogeneous conditions. Here, we sought to identify a neurobiological signature
Wei Wu   +26 more
semanticscholar   +1 more source

ANet: Autoencoder-Based Local Field Potential Feature Extractor for Evaluating An Antidepressant Effect in Mice after Administering Kratom Leaf Extracts [PDF]

open access: yesarXiv, 2022
Kratom (KT) typically exerts antidepressant (AD) effects. However, evaluating which form of KT extracts possesses AD properties similar to the standard AD fluoxetine (flu) remained challenging. Here, we adopted an autoencoder (AE)-based anomaly detector called ANet to measure the similarity of mice's local field potential (LFP) features that responded ...
arxiv  

GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.

open access: yesJournal of Clinical Investigation, 2019
A single sub-anesthetic dose of ketamine, an NMDA receptor (NMDAR) antagonist, produces rapid and sustained antidepressant actions in depressed patients, addressing a major unmet need for the treatment of mood disorders.
Danielle M. Gerhard   +11 more
semanticscholar   +1 more source

The Ghrelin/Growth Hormone Secretagogue Receptor System Is Involved in the Rapid and Sustained Antidepressant-Like Effect of Paeoniflorin

open access: yesFrontiers in Neuroscience, 2021
Major depressive disorder (MDD) is a debilitating mental illness affecting people worldwide. Although significant progress has been made in the development of therapeutic agents to treat this condition, fewer than half of all patients respond to ...
Yuan Zhang   +13 more
doaj   +1 more source

5-HT2A mediated plasticity as a target in major depression: a narrative review connecting the dots from neurobiology to cognition and psychology [PDF]

open access: yesarXiv, 2020
As the world's first primary morbidity factor, depression has a considerable impact on both an individual as well as a societal level. despite their discovery several decades ago, classical antidepressants have been shown to provide limited benefits against this condition.
arxiv  

Antidepressant effect of Gentiana olivieri Griseb. in male rats exposed to chronic mild stress

open access: yesLibyan Journal of Medicine, 2020
Background: The flowering parts of Gentiana olivieri, known as ‘Afat’ in the southeastern Anatolia region of Turkey, are used as a tonic, an appetizer, and for the treatment of several mental disorders, including depression.
Ahmet Berk   +5 more
doaj   +1 more source

Pronounced Inter-Individual Variation in Plasma Cortisol Response to Fluoxetine Hydrochloride in the Pig

open access: yesAnimals, 2020
Animal welfare assessment requires measures for positive affective state. Pharmacological agents that manipulate affective state can be used to evaluate novel biomarkers for affective state assessment.
Laura E. Marsh   +4 more
doaj   +1 more source

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

open access: yesAmerican Journal of Psychiatry, 2018
OBJECTIVE: In addition to N-methyl-d-aspartate receptor antagonism, ketamine produces opioid system activation. The objective of this study was to determine whether opioid receptor antagonism prior to administration of intravenous ketamine attenuates its
N. Williams   +10 more
semanticscholar   +1 more source

Antidepressant Potential of Quercetin and its Glycoside Derivatives: A Comprehensive Review and Update

open access: yesFrontiers in Pharmacology, 2022
Depression is a global health problem with growing prevalence rates and serious impacts on the daily life of patients. However, the side effects of currently used antidepressants greatly reduce the compliance of patients.
Shen Chen   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy